Sandra McCurdy

Absence of the P2X7 receptor alters leukocyte function and attenuates an inflammatory response.

Evaluation of consumer-style cooking methods for reduction of Escherichia coli O157:H7 in ground beef.

Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitor.

The novel JAK-3 inhibitor CP-690550 is a potent immunosuppressive agent in various murine models.

Renal function and survival after renal artery stent revascularization may be influenced by embolic debris.

Gem No. 401. Food thermometer educational materials: "Now You're Cooking... Using a Food Thermometer!".

Educational intervention enhances consumers' readiness to adopt food thermometer use when cooking small cuts of meat: an application of the transtheoretical model.

Development and validation of stages-of-change questions to assess consumers' readiness to use a food thermometer when cooking small cuts of meat.

A comparison of students from main and alternate admission lists at one school: the potential impact on student performance of increasing enrollment.

Pyrimidine benzamide-based thrombopoietin receptor agonists.

Molecular features crucial to the activity of pyrimidine benzamide-based thrombopoietin receptor agonists.

The identification of orally bioavailable thrombopoietin agonists.

5-(2-Pyrimidinyl)-imidazo[1,2-a]pyridines are antibacterial agents targeting the ATPase domains of DNA gyrase and topoisomerase IV.

Structure-activity relationships and hepatic safety risks of thiazole agonists of the thrombopoietin receptor.

Emergence of linezolid-resistant coagulase-negative Staphylococcus in a cancer centre linked to increased linezolid utilization.

Multicity outbreak of linezolid-resistant Staphylococcus epidermidis associated with clonal spread of a cfr-containing strain.

Successful eradication of a monoclonal strain of Klebsiella pneumoniae during a K. pneumoniae carbapenemase-producing K. pneumoniae outbreak in a surgical intensive care unit in Miami, Florida.

Scholars in Rural Health: outcomes from an assured admissions program.

Discovery of CP-690,550: a potent and selective Janus kinase (JAK) inhibitor for the treatment of autoimmune diseases and organ transplant rejection.

Novel monobactams utilizing a siderophore uptake mechanism for the treatment of gram-negative infections.

Novel 3-O-carbamoyl erythromycin A derivatives (carbamolides) with activity against resistant staphylococcal and streptococcal isolates.

Novel quinoline derivatives as inhibitors of bacterial DNA gyrase and topoisomerase IV.

Discovery of Dap-3 polymyxin analogues for the treatment of multidrug-resistant Gram-negative nosocomial infections.

Pyridone-conjugated monobactam antibiotics with gram-negative activity.

Siderophore receptor-mediated uptake of lactivicin analogues in gram-negative bacteria.

In Vitro Activity of Dalbavancin against Drug-Resistant Staphylococcus aureus Isolates from a Global Surveillance Program.